The patent for the detection and isolation of the SARS-CoV coronavirus belongs to the US government, a Rossa Primavera News Agency correspondent reports on March 19.
The document states that the patent application for the SARS-CoV coronavirus was filed on April 25, 2003.
The patent contains information about the “newly isolated human coronavirus (SARS-CoV), the causative agent of severe acute respiratory syndrome (SARS). Also provided are the nucleic acid sequence of the SARS-CoV genome and the amino acid sequences of the SARS-CoV open reading frames, as well as methods of using these molecules to detect SARS-CoV and detect infections therewith,” says the document.
The invention was made by federal employees in the US Department of Health and Human Services. Additional recordings in regards to this document were made in 2004 and 2007.
The invention is related to detection methods of a coronavirus associated with severe acute respiratory syndrome. The document specifically describes spherical coronaviruses, 100-160 nm in diameter.
The size of the SARS-CoV coronavirus correlates with the size of the of the SARS-Cov-2 coronavirus (COVID-19) which can be seen on the image recently published by researchers at the VECTOR State Research Center of Virology and Biotechnology in the Russian city of Novosibirsk. It is approximately 100 nm in diameter.
The document next provides a detailed description of the SARS-CoV coronavirus and its genome, as well as methods for its detection.
The complete genome of the coronavirus SARS-Cov-2 was published by UC Santa Cruz on January 29, 2020.
According to the authors of the publication in the journal Nature, the genomic sequences of both viruses that cause severe pneumonia and belong to the same family: SARS-Cov and SARS-Сov2, are quite similar.
It should be noted that the former UN expert on biological weapons Igor Nikulin said that the coronavirus was developed in the US in 2015.
In 2015, the journal Nature published an article about a successful experiment by US scientists on the modification of a Chinese bat coronavirus. A human protein was introduced into its genomic sequence. As a result of the modification, the virus was able to directly penetrate into human cells. Nature has published separate clarifications on this subject.
At the end of 2019, a new type of coronavirus was discovered in the Chinese city of Wuhan, causing pneumonia in humans with unusual symptoms. Subsequently, similar cases were also reported in Australia, South Korea, Nepal, Malaysia, Japan, the United States, France and Canada. On January 31, the first two cases were confirmed in Russia.
China is adopting decisive measures to fight the infection. In particular, the PRC authorities quarantined the cities where the epicenters of the outbreak were discovered, and mobilized military and civilian doctors to provide assistance and conduct examinations of citizens. New hospitals are being built in record time. A number of countries closed their borders with China, many airlines canceled regular flights to Beijing and other cities of the country.
Source: Rossa Primavera News Agency